Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Peroxisome proliferator-activated receptor alpha (Homo sapiens (Human)) | BDBM232289 (US9346770, 2) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a |
ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. US Patent | Assay Description After 24 h treatment with the medicament, the cells were lysed with a lysis solution (Cell Culture Lysis buffer, Promega) and centrifuged, and the su... | US Patent US9346770 (2016) BindingDB Entry DOI: 10.7270/Q21Z438X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Peroxisome proliferator-activated receptor delta (Homo sapiens (Human)) | BDBM232291 (US9346770, 4) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 851 | n/a | n/a | n/a | n/a |
ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. US Patent | Assay Description After 24 h treatment with the medicament, the cells were lysed with a lysis solution (Cell Culture Lysis buffer, Promega) and centrifuged, and the su... | US Patent US9346770 (2016) BindingDB Entry DOI: 10.7270/Q21Z438X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Peroxisome proliferator-activated receptor alpha (Homo sapiens (Human)) | BDBM232293 (US9346770, 6) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.63E+3 | n/a | n/a | n/a | n/a |
ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. US Patent | Assay Description After 24 h treatment with the medicament, the cells were lysed with a lysis solution (Cell Culture Lysis buffer, Promega) and centrifuged, and the su... | US Patent US9346770 (2016) BindingDB Entry DOI: 10.7270/Q21Z438X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Peroxisome proliferator-activated receptor gamma (Homo sapiens (Human)) | BDBM232289 (US9346770, 2) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 692 | n/a | n/a | n/a | n/a |
ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. US Patent | Assay Description After 24 h treatment with the medicament, the cells were lysed with a lysis solution (Cell Culture Lysis buffer, Promega) and centrifuged, and the su... | US Patent US9346770 (2016) BindingDB Entry DOI: 10.7270/Q21Z438X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Peroxisome proliferator-activated receptor gamma (Homo sapiens (Human)) | BDBM232294 (US9346770, 7) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 25 | n/a | n/a | n/a | n/a |
ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. US Patent | Assay Description After 24 h treatment with the medicament, the cells were lysed with a lysis solution (Cell Culture Lysis buffer, Promega) and centrifuged, and the su... | US Patent US9346770 (2016) BindingDB Entry DOI: 10.7270/Q21Z438X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Peroxisome proliferator-activated receptor gamma (Homo sapiens (Human)) | BDBM232296 (US9346770, 9) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 47 | n/a | n/a | n/a | n/a |
ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. US Patent | Assay Description After 24 h treatment with the medicament, the cells were lysed with a lysis solution (Cell Culture Lysis buffer, Promega) and centrifuged, and the su... | US Patent US9346770 (2016) BindingDB Entry DOI: 10.7270/Q21Z438X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Peroxisome proliferator-activated receptor gamma (Homo sapiens (Human)) | BDBM50030474 (Avandamet | Avandaryl | Avandia | BRL-49653 | CHEB...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | Purchase DrugBank MCE PC cid PC sid PDB UniChem Similars | DrugBank PDB US Patent | n/a | n/a | n/a | n/a | 1 | n/a | n/a | n/a | n/a |
ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. US Patent | Assay Description After 24 h treatment with the medicament, the cells were lysed with a lysis solution (Cell Culture Lysis buffer, Promega) and centrifuged, and the su... | US Patent US9346770 (2016) BindingDB Entry DOI: 10.7270/Q21Z438X | |||||||||||
More data for this Ligand-Target Pair | 3D Structure (crystal) | ||||||||||||
Peroxisome proliferator-activated receptor alpha (Homo sapiens (Human)) | BDBM232292 (US9346770, 5) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.18E+3 | n/a | n/a | n/a | n/a |
ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. US Patent | Assay Description After 24 h treatment with the medicament, the cells were lysed with a lysis solution (Cell Culture Lysis buffer, Promega) and centrifuged, and the su... | US Patent US9346770 (2016) BindingDB Entry DOI: 10.7270/Q21Z438X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Peroxisome proliferator-activated receptor gamma (Homo sapiens (Human)) | BDBM232288 (US9346770, 1) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 13 | n/a | n/a | n/a | n/a |
ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. US Patent | Assay Description After 24 h treatment with the medicament, the cells were lysed with a lysis solution (Cell Culture Lysis buffer, Promega) and centrifuged, and the su... | US Patent US9346770 (2016) BindingDB Entry DOI: 10.7270/Q21Z438X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Peroxisome proliferator-activated receptor delta (Homo sapiens (Human)) | BDBM232290 (US9346770, 3) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <1 | n/a | n/a | n/a | n/a |
ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. US Patent | Assay Description After 24 h treatment with the medicament, the cells were lysed with a lysis solution (Cell Culture Lysis buffer, Promega) and centrifuged, and the su... | US Patent US9346770 (2016) BindingDB Entry DOI: 10.7270/Q21Z438X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Peroxisome proliferator-activated receptor delta (Homo sapiens (Human)) | BDBM232294 (US9346770, 7) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3 | n/a | n/a | n/a | n/a |
ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. US Patent | Assay Description After 24 h treatment with the medicament, the cells were lysed with a lysis solution (Cell Culture Lysis buffer, Promega) and centrifuged, and the su... | US Patent US9346770 (2016) BindingDB Entry DOI: 10.7270/Q21Z438X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Peroxisome proliferator-activated receptor alpha (Homo sapiens (Human)) | BDBM232288 (US9346770, 1) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 29 | n/a | n/a | n/a | n/a |
ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. US Patent | Assay Description After 24 h treatment with the medicament, the cells were lysed with a lysis solution (Cell Culture Lysis buffer, Promega) and centrifuged, and the su... | US Patent US9346770 (2016) BindingDB Entry DOI: 10.7270/Q21Z438X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Peroxisome proliferator-activated receptor alpha (Homo sapiens (Human)) | BDBM232290 (US9346770, 3) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 4 | n/a | n/a | n/a | n/a |
ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. US Patent | Assay Description After 24 h treatment with the medicament, the cells were lysed with a lysis solution (Cell Culture Lysis buffer, Promega) and centrifuged, and the su... | US Patent US9346770 (2016) BindingDB Entry DOI: 10.7270/Q21Z438X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Peroxisome proliferator-activated receptor alpha (Homo sapiens (Human)) | BDBM232294 (US9346770, 7) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | KEGG PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.88E+3 | n/a | n/a | n/a | n/a |
ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. US Patent | Assay Description After 24 h treatment with the medicament, the cells were lysed with a lysis solution (Cell Culture Lysis buffer, Promega) and centrifuged, and the su... | US Patent US9346770 (2016) BindingDB Entry DOI: 10.7270/Q21Z438X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Peroxisome proliferator-activated receptor gamma (Homo sapiens (Human)) | BDBM232295 (US9346770, 8) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 22 | n/a | n/a | n/a | n/a |
ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. US Patent | Assay Description After 24 h treatment with the medicament, the cells were lysed with a lysis solution (Cell Culture Lysis buffer, Promega) and centrifuged, and the su... | US Patent US9346770 (2016) BindingDB Entry DOI: 10.7270/Q21Z438X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Peroxisome proliferator-activated receptor delta (Homo sapiens (Human)) | BDBM232293 (US9346770, 6) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 6.76E+3 | n/a | n/a | n/a | n/a |
ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. US Patent | Assay Description After 24 h treatment with the medicament, the cells were lysed with a lysis solution (Cell Culture Lysis buffer, Promega) and centrifuged, and the su... | US Patent US9346770 (2016) BindingDB Entry DOI: 10.7270/Q21Z438X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Peroxisome proliferator-activated receptor alpha (Homo sapiens (Human)) | BDBM232296 (US9346770, 9) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.15E+3 | n/a | n/a | n/a | n/a |
ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. US Patent | Assay Description After 24 h treatment with the medicament, the cells were lysed with a lysis solution (Cell Culture Lysis buffer, Promega) and centrifuged, and the su... | US Patent US9346770 (2016) BindingDB Entry DOI: 10.7270/Q21Z438X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Peroxisome proliferator-activated receptor delta (Homo sapiens (Human)) | BDBM232296 (US9346770, 9) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 331 | n/a | n/a | n/a | n/a |
ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. US Patent | Assay Description After 24 h treatment with the medicament, the cells were lysed with a lysis solution (Cell Culture Lysis buffer, Promega) and centrifuged, and the su... | US Patent US9346770 (2016) BindingDB Entry DOI: 10.7270/Q21Z438X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Peroxisome proliferator-activated receptor delta (Homo sapiens (Human)) | BDBM50030474 (Avandamet | Avandaryl | Avandia | BRL-49653 | CHEB...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | Purchase DrugBank MCE PC cid PC sid PDB UniChem Similars | US Patent | n/a | n/a | n/a | n/a | 5.25E+3 | n/a | n/a | n/a | n/a |
ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. US Patent | Assay Description After 24 h treatment with the medicament, the cells were lysed with a lysis solution (Cell Culture Lysis buffer, Promega) and centrifuged, and the su... | US Patent US9346770 (2016) BindingDB Entry DOI: 10.7270/Q21Z438X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Peroxisome proliferator-activated receptor gamma (Homo sapiens (Human)) | BDBM232291 (US9346770, 4) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 89 | n/a | n/a | n/a | n/a |
ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. US Patent | Assay Description After 24 h treatment with the medicament, the cells were lysed with a lysis solution (Cell Culture Lysis buffer, Promega) and centrifuged, and the su... | US Patent US9346770 (2016) BindingDB Entry DOI: 10.7270/Q21Z438X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Peroxisome proliferator-activated receptor gamma (Homo sapiens (Human)) | BDBM232293 (US9346770, 6) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 6.76E+3 | n/a | n/a | n/a | n/a |
ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. US Patent | Assay Description After 24 h treatment with the medicament, the cells were lysed with a lysis solution (Cell Culture Lysis buffer, Promega) and centrifuged, and the su... | US Patent US9346770 (2016) BindingDB Entry DOI: 10.7270/Q21Z438X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Peroxisome proliferator-activated receptor gamma (Homo sapiens (Human)) | BDBM232290 (US9346770, 3) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 5 | n/a | n/a | n/a | n/a |
ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. US Patent | Assay Description After 24 h treatment with the medicament, the cells were lysed with a lysis solution (Cell Culture Lysis buffer, Promega) and centrifuged, and the su... | US Patent US9346770 (2016) BindingDB Entry DOI: 10.7270/Q21Z438X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Peroxisome proliferator-activated receptor gamma (Homo sapiens (Human)) | BDBM232292 (US9346770, 5) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 4 | n/a | n/a | n/a | n/a |
ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. US Patent | Assay Description After 24 h treatment with the medicament, the cells were lysed with a lysis solution (Cell Culture Lysis buffer, Promega) and centrifuged, and the su... | US Patent US9346770 (2016) BindingDB Entry DOI: 10.7270/Q21Z438X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Peroxisome proliferator-activated receptor delta (Homo sapiens (Human)) | BDBM232288 (US9346770, 1) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 29 | n/a | n/a | n/a | n/a |
ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. US Patent | Assay Description After 24 h treatment with the medicament, the cells were lysed with a lysis solution (Cell Culture Lysis buffer, Promega) and centrifuged, and the su... | US Patent US9346770 (2016) BindingDB Entry DOI: 10.7270/Q21Z438X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Peroxisome proliferator-activated receptor delta (Homo sapiens (Human)) | BDBM232292 (US9346770, 5) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 7 | n/a | n/a | n/a | n/a |
ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. US Patent | Assay Description After 24 h treatment with the medicament, the cells were lysed with a lysis solution (Cell Culture Lysis buffer, Promega) and centrifuged, and the su... | US Patent US9346770 (2016) BindingDB Entry DOI: 10.7270/Q21Z438X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Peroxisome proliferator-activated receptor delta (Homo sapiens (Human)) | BDBM232295 (US9346770, 8) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 6 | n/a | n/a | n/a | n/a |
ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. US Patent | Assay Description After 24 h treatment with the medicament, the cells were lysed with a lysis solution (Cell Culture Lysis buffer, Promega) and centrifuged, and the su... | US Patent US9346770 (2016) BindingDB Entry DOI: 10.7270/Q21Z438X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Peroxisome proliferator-activated receptor alpha (Homo sapiens (Human)) | BDBM232295 (US9346770, 8) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 5.25E+3 | n/a | n/a | n/a | n/a |
ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. US Patent | Assay Description After 24 h treatment with the medicament, the cells were lysed with a lysis solution (Cell Culture Lysis buffer, Promega) and centrifuged, and the su... | US Patent US9346770 (2016) BindingDB Entry DOI: 10.7270/Q21Z438X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Peroxisome proliferator-activated receptor delta (Homo sapiens (Human)) | BDBM232289 (US9346770, 2) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <1 | n/a | n/a | n/a | n/a |
ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. US Patent | Assay Description After 24 h treatment with the medicament, the cells were lysed with a lysis solution (Cell Culture Lysis buffer, Promega) and centrifuged, and the su... | US Patent US9346770 (2016) BindingDB Entry DOI: 10.7270/Q21Z438X | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Peroxisome proliferator-activated receptor alpha (Homo sapiens (Human)) | BDBM232291 (US9346770, 4) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 5.50E+3 | n/a | n/a | n/a | n/a |
ZHEJIANG HISUN PHARMACEUTICAL CO., LTD. US Patent | Assay Description After 24 h treatment with the medicament, the cells were lysed with a lysis solution (Cell Culture Lysis buffer, Promega) and centrifuged, and the su... | US Patent US9346770 (2016) BindingDB Entry DOI: 10.7270/Q21Z438X | |||||||||||
More data for this Ligand-Target Pair |